Tumor mutational burden profile (TMB) of oncogenic driver mutations in non small cell lung cancer

被引：0
|
作者：
Walker, Paul [1 ]
Sharma, Nitika [1 ]
机构：
[1] East Carolina Univ, Greenville, NC 27858 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P106
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Tumor mutational burden (TMB) as a biomarker of response to immunotherapy in small cell lung cancer
    Boumber, Yanis
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (08) : 4689 - 4693
  • [2] Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer
    Chae, Young Kwang
    Davis, Andrew A.
    Agte, Sarita
    Pan, Alan
    Simon, Nicholas I.
    Iams, Wade T.
    Cruz, Marcelo R.
    Tamragouri, Keerthi
    Rhee, Kyunghoon
    Mohindra, Nisha
    Villaflor, Victoria
    Park, Wungki
    Lopes, Gilberto
    Giles, Francis J.
    [J]. ONCOLOGIST, 2019, 24 (06): : 820 - 828
  • [3] Non-Small Cell Lung Cancer as a Precision Oncology Paradigm: Emerging Targets and Tumor Mutational Burden (TMB)
    Tafe, Laura J.
    [J]. ADVANCES IN ANATOMIC PATHOLOGY, 2020, 27 (01) : 3 - 10
  • [4] ONCOGENIC DRIVER MUTATIONS IN CHINESE NON-SMALL CELL LUNG CANCER (NSCLC)
    He, J.
    Yang, H.
    Deng, Q.
    He, P.
    Jiang, J.
    Zhao, M.
    Gu, X.
    Zheng, L.
    Pang, H.
    Zhou, J. X.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 389 - 390
  • [5] Clinical Potential of Tissue Tumor Mutational Burden (tTMB) and Blood TMB (bTMB) as a Biomarker in Non-Small Cell Lung Cancer
    Zhou, J.
    Zhou, J.
    Chen, X.
    Zhu, Y.
    Fang, L.
    Bao, Z.
    Liu, R.
    Cao, H.
    Sun, W.
    Zhang, T.
    Lin, J.
    Yu, B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S370 - S370
  • [6] Uncommon EGFR mutations are associated with higher tumor mutation burden (TMB) in non-small cell lung cancer patients
    Shen, Xudong
    Zhang, Hushan
    Huang, Depei
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [7] Oncogenic driver mutations in non-small cell lung cancer: Past, present and future
    Chevallier, Mathieu
    Borgeaud, Maxime
    Addeo, Alfredo
    Friedlaender, Alex
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (04): : 217 - 237
  • [8] The clinical utility of tumor mutational burden in non-small cell lung cancer
    Greillier, Laurent
    Tomasini, Pascale
    Barlesi, Fabrice
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (06) : 639 - 646
  • [9] Comparison of platforms for determining tumor mutational burden (TMB) from blood samples in patients with non-small cell lung cancer (NSCLC)
    Baden, J.
    Chang, H.
    Greenawalt, D. M.
    Kirov, S.
    Pant, S.
    Seminara, A.
    Srinivasan, S.
    Green, G.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 28 - 28
  • [10] Comparison of platforms for determining tumour mutational burden (TMB) in patients with non-small cell lung cancer (NSCLC)
    Baden, J.
    Zhao, C.
    Pratt, J.
    Kirov, S.
    Pant, S.
    Seminara, A.
    Green, G.
    Bilke, S.
    Deras, I.
    Fabrizio, D. A.
    Pawlowski, T.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 25 - 25
12345